Europe CEO
Date: Location: Cost:
March 24, 2019 Vienna Marriott Hotel
Parkring 12a
1010 Wien, Vienna Austria
43 1 515180
Location >

Starting at $1950

 

Dress Code:
Business Attire

Register

Past Agenda - March 2018

Co-hosts & Speakers include:

Adam Bruce, CEO, TikoMed; Roel Bulthuis, Senior Vice President & Managing Director, Merck Ventures; Robert Darwin, Partner, London, Hogan Lovells; Dee Datta, Chief Business Officer, Xoma; Don deBethizyChairman, Albumedix; Jonathan Lewis, Chairman & CEO, Samus Therapeutics; Dirk Kersten, Managing Director, Inkef Capital; Thomas Lonngren, former Executive Director, EMA; Philippe Lopes-FernandesSVP Global Head BD & Alliance Management, EMD Serono; Giovanni Marriggi, Principal, Growth Stage Clinical Opportunities, Medicxi; Elias Papatheodorou, CEO, Genkyotex; Nathalie Rowell, Founder, Virdis Group; Sander Slootweg, Managing PartnerForbion Capital Partners; Paul-Peter Tak, SVP/Global Head, Immuno-Inflammation Research & Clinical Development, GSK; Bharat Tewarie, EVP & CMO, UCB; Hein van den Bos, Partner, Amsterdam, Hogan Lovells; Nikolay Zhukovsky, CEO, BioXpress Therapeutics


Time Agenda
8:30-9:30 am

Registration & Networking Breakfast 

9:30-9:45 am

Welcome & Opening Remarks
Robert Darwin
; Partner, London, Hogan Lovells; Thomas LonngrenFormer Executive Director, EMA

9:45-10:30 am

What EU Biotech Need to Know About Accessing Financing in the USA
Dee Datta, Chief Business Officer, Xoma; Don deBethizy, Chairman, Albumedix; Richard Godfrey, CEO, BerGenBio; Amanda HaywardExecutive ChairHoba Therapeutics
Moderator: Nicholas Moore, Managing Director, Stifel

10:30-11:00 am

Keynote Chat: Developing a First In Class Drug in the Competitive Oncology Therapeutic Space
Don deBethizy, Chairman, Albumedix; Richard Godfrey, CEO, BerGenBio

11:00-11:30 am

Networking Break 

11:30-12:00 pm

Fireside Chat: Driving Innovation & Drug Development in Global Markets
Gilmore O'Neill, SVP Late Stage Clinical Development, Biogen; Paul-Peter Tak
SVP Immunology Network, GSK
Moderator: Jonathan Lewis, Chairman & CEO, Samus Therapeutics

12:00-12:45 pm

European VC Perspectives
Hubert BirnerManaging Partner, TVM Capital Life Science; Dirk KerstenManaging Director, Inkef Capital; Sander Slootweg, Managing Partner, Forbion Capital Partners
Moderator Roel Bulthuis, Senior Vice President & Managing Director, Merck Ventures

12:45-1:45 pm

Networking Lunch 

1:45-2:15 pm

Building a Biotech: Strategies for Success
Adam BruceCEO, TikoMed; Nathalie Rowell, Founder, Virdis Group; Nikolay Zhukovsky, CEO, BioXpress Therapeutics
Moderator: Dorte Gram, CEO, Pila Pharma

2:15-2:45 pm

Biotech Deal-Making, Partnerships and Collaborations 
Dorte Gram, CEO, Pila Pharma; David Meininger, Chief Business Officer, Trianni; Bharat Tewarie, EVP & CMO, UCB
Moderator Robert DarwinPartner, London, Hogan Lovells

2:45-3:15 pm

Networking Break

3:15-4:00 pm

Regulatory Outlook: Market Access in the US vs Europe
Franz Buchholzer, Vice President, Global Regulatory Affairs, Santen; Thomas LonngrenFormer Executive Director, EMA; David Setboun, President & Managing Director, Biogen
Moderator: Hein van dan BosPartner, Amsterdam, Hogan Lovells

4:00-4:15 pm

Closing Remarks 

4:15-5:15 pm

Cocktails and Hors d'oeuvres

Supporting Sponsors: (see all sponsors)

<